Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 4, Number 2—June 1998
Synopsis

Agricultural Use of Burkholderia (Pseudomonas) cepacia: A Threat to Human Health?

Alison H. Holmes*Comments to Author , John Govan†, and Richard Goldstein‡
Author affiliations: *Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom; †University of Edinburgh Medical School, Edinburgh, United Kingdom; ‡Maxwell Finland Laboratory for Infectious Diseases, BostonUniversity School of Medicine, Boston, Massachusetts, USA

Main Article

Figure 1

B. cepacia causes an onion rot known as slippery skin (1). The onions shown were inoculated with three strains of B. cepacia. Rot occurred in onion1 (left), which was inoculated with strain originally isolated from onions. Rot did not occur with environmental isolates tested or with strains from CF lung.

Figure 1. B. cepacia causes an onion rot known as slippery skin (1). The onions shown were inoculated with three strains of B. cepacia. Rot occurred in onion1 (left), which was inoculated with strain originally isolated from onions. Rot did not occur with environmental isolates tested or with strains from CF lung.

Main Article

References
  1. Burkholder  W. Sour skin, a bacterial rot of onion bulbs. Phytopathology. 1950;40:115–8.
  2. Goldmann  D, Klinger  J. Pseudomonas cepacia: Biology, mechanisms of virulence, epidemiology. J Pediatr. 1986;108:806–12. DOIPubMedGoogle Scholar
  3. Thomassen  MJ, Demko  C, Klinger  J, Stern  R. Pseudomonas cepacia colonization among patients with cystic fibrosis—a new opportunist. Am Rev Respir Dis. 1985;131:791–6.PubMedGoogle Scholar
  4. Sajjan  U, Sun  L, Goldstein  R, Forstner  J. Cable (Cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol. 1995;177:1030–8.PubMedGoogle Scholar
  5. Pseudomonas cepacia—more than a harmless commensal? [editorial]. Lancet. 1992;329:1385–6.
  6. Govan  J, Deretic  V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev. 1996;60:539–74.PubMedGoogle Scholar
  7. Isles  A, Maclusky  I, Corey  M, Gold  R, Prober  C, Fleming  P, Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984;104:206–10. DOIPubMedGoogle Scholar
  8. Tablan  O, Chorba  T, Schidlow  D, White  J, Hardy  K, Gilligan  P, Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985;107:382–7. DOIPubMedGoogle Scholar
  9. Thomassen  MJ, Demko  C, Doershuk  C, Stern  R, Klinger  J. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis. 1986;134:669–71.PubMedGoogle Scholar
  10. Tablan  O, Martone  W, Coershuk  D, Stern  R, Thomassen  MJ, Klinger  J, Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Chest. 1987;91:527–32. DOIPubMedGoogle Scholar
  11. Corey  M, Farewell  V. Determinants of mortality from cystic fibrosis in Canada. Am J Epidemiol. 1996;143:1007–17.PubMedGoogle Scholar
  12. Govan  J, Brown  P, Maddison  J, Doherty  C, Nelson  J, Dodd  M, Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993;342:15–9. DOIPubMedGoogle Scholar
  13. Walters  S, Smith  E. Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications. Lancet. 1993;342:3–4.PubMedGoogle Scholar
  14. Hearst  J, Elliott  K. Identifying the killer in cystic fibrosis. Understanding the genetic defects underlying CF is only half the battle. Identifying the specific bacterium infecting CF patients is just as important. Nat Med. 1995;1:626–7. DOIPubMedGoogle Scholar
  15. LiPuma  J, Mortensen  J, Dasen  S, Stull  T. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr. 1988;113:859–62. DOIPubMedGoogle Scholar
  16. Johnson  W, Tyler  S, Rozee  K. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol. 1994;32:924–30.PubMedGoogle Scholar
  17. Mahenthiralingam  E, Simpson  D, Speert  D. Identification and characterisation of a novel DNA marker associated with epidemic strains recovered from patients with cystic fibrosis. J Clin Microbiol. 1997;35:808–16.PubMedGoogle Scholar
  18. Sun  L, Jiang  R-Z, Steinbach  S, Holmes  A, Campanelli  C, Forstner  J, The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med. 1995;1:661–6. DOIPubMedGoogle Scholar
  19. Pitt  T, Kaufmann  M, Patel  P, Benge  L, Gaskin  S, Livermore  D. Type characterization and antibiotic susceptibility of Burkholderia (pseudomonas) cepacia isolated from patients with cystic fibrosis in the United Kingdom and Republic of Ireland. J Med Microbiol. 1996;44:203–10. DOIPubMedGoogle Scholar
  20. Segonds  C, Bingen  B, Couetdic  G, Mathy  S, Brahimy  N, Narty  N, Genotypic Analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol. 1997;35:2055–60.PubMedGoogle Scholar
  21. Steinbach  S, Sun  L, Jiang  R, Flume  P, Gilligan  P, Egan  T, Transmissibility of Pseudomonas cepacia infections in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med. 1994;331:981–7. DOIPubMedGoogle Scholar
  22. Ryley  H, Ojeniyi  B, Hoiby  N, Weeks  J. Lack of evidence of cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 1996;15:755–9. DOIPubMedGoogle Scholar
  23. Govan  J, Hughes  J, Vandamme  P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol. 1996;45:395–407. DOIPubMedGoogle Scholar
  24. Taplin  D, Bassett  D, Mertz  P. Foot lesions associated with Pseudomonas cepacia. Lancet. 1971;:568–71.PubMedGoogle Scholar
  25. Jarvis  W, Olson  D, Tablan  O, Martone  J. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol. 1987;3:233–6. DOIPubMedGoogle Scholar
  26. Anderson  D, Kuhns  J, Vasil  M, Gerding  D, Janoff  E. DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol. 1991;29:648–9.PubMedGoogle Scholar
  27. Pegues  D, Carson  L, Anderson  R, Norgard  M, Argent  T, Jarvis  W, Outbreak of Pseudomonas cepacia in oncology patients. Clin Infect Dis. 1993;16:407–14.PubMedGoogle Scholar
  28. Dixon  R, Ksalow  D, Mackel  C, Fulkerson  C, Mollison  G. Aqueous quaternary ammonium antiseptics and disinfectants—use and misuse. JAMA. 1977;236:2415–7. DOIGoogle Scholar
  29. Sobel  J, Hashman  N, Reinherz  G, Merzbach  D. Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med. 1982;73:183–6. DOIPubMedGoogle Scholar
  30. Hyde  J, Humphreys  H. Absence of Burkholderia cepacia from the respiratory tract of non-cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 1997;16:253–4. DOIPubMedGoogle Scholar
  31. Holmes  A, Nolan  R, Finley  R, Riley  M, Sun  L, Goldstein  R. An epidemic clone of Burkholderia (Pseudomonas) cepacia transmitted between cystic fibrosis and non-cystic fibrosis patients. In Abstracts of the 9th Annual North American Cystic Fibrosis Conference; 1995; Dallas, Texas. Dallas (TX): Cystic Fibrosis Foundation; 1995, abstract 228.
  32. Tablan  O, Chorba  T, Schidlow  D, White  J, Hardy  K, Gilligan  P, Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1984;107:382–7. DOIGoogle Scholar
  33. Carson  L, Tablan  O, Cusick  L, Jarvis  W, Favero  M, Bland  L. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental source. J Clin Microbiol. 1988;26:2096–100.PubMedGoogle Scholar
  34. Gilligan  P, Gage  P, Bradshaw  L, Schidlow  D, DeCicco  B. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 1985;22:5–8.PubMedGoogle Scholar
  35. McLoughlin  T, Quinn  J, Bettermann  A, Bookland  R. Pseudomonas cepacia suppression of sunflower wilt fungus and role of antifungal compounds in controlling disease. Appl Environ Microbiol. 1992;58:1760–3.PubMedGoogle Scholar
  36. Homma  Y, Sato  Z, Hirayama  F, Kanno  K, Shirahama  H, Suzui  T. Production of antibiotics by Pseudomonas cepacia as an agent for biological control of soilborne pathogens. Soil Biol Biochem. 1989;21:723–8. DOIGoogle Scholar
  37. Sangodkar  U, Chapman  P, Chakrabarty  A. Cloning, physical mapping and expression of chromosomal genes specifying degradation of the herbicide 2,4,5-T by Pseudomonas cepacia AC1100. Gene. 1988;71:267–77. DOIPubMedGoogle Scholar
  38. Tabacchioni  S, Visca  P, Chiarini  L, Bevivino  A, Di Serio  C, Francelli  S, Molecular characterization of rhizosphere and clinical isolates of Burkholderia cepacia. Res Microbiol. 1995;146:531–42. DOIPubMedGoogle Scholar
  39. Bowers  J, Parke  J. Epidemiology of Pythium damping-off and Aphanomyces root rot of peas after seed treatment with bacterial agents for biological control. Phytopathology. 1993;83:1466–73. DOIGoogle Scholar
  40. King  E, Parke  J. Population density of the biocontrol agent Burkholderia cepacia AMMDR1 on four pea cultivars. Soil Biol Biochem. 1996;28:306–12. DOIGoogle Scholar
  41. Joy  A, Parke  J. Biocontrol of Alternaria leaf blight on American ginseng by Burkholderia cepacia AMMD. In: Bailey WG, Whitehead C, Procter JTA, Kyle JT, editors. Challenges of the 21st century. Proceedings of the International Ginseng Conference; 1994; Vancouver, British Columbia, Canada. Burnaby, B.C., Canada: Simon Fraser Univ.; 1994.
  42. Cartwright  D, Chilton  C, Benson  D. Pyrrolnitrin and phenazine production by Pseudomonas cepacia strain 5.5B, a biocontrol agent of Rhizoctonia solani. Appl Microbiol Biotechnol. 1995;43:211–6. DOIGoogle Scholar
  43. Reddy  M. Status on commercial development of Burkholderia cepacia for biological control of fungal pathogens and growth enhancement of conifer seedlings for a global market. Washington: US Forest service general technical report PNW; 1997. Report no. 389. p. 235-44.
  44. Wise  M, Shimkets  L, McArthur  J. Genetic structure of a lotic population of Burkholderia (Pseudomonas) cepacia. Appl Environ Microbiol. 1995;61:1791–8.PubMedGoogle Scholar
  45. Ursing  JB, Rosello-Mora  RA, Garcia-Valdes  E, Lalcut  J. A pragmatic approach to the nomenclature of phenotypically similar genomic groups. Int J Syst Bacteriol. 1995;45:604. DOIGoogle Scholar
  46. Vandamme  P, Holmes  B, Vancanneyt  M, Coenye  T, Hoste  B, Coopman  R, Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp nov. Int J Syst Bacteriol. 1997;47:1188–200. DOIPubMedGoogle Scholar
  47. Cheng  H, Lessie  T. Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J Bacteriol. 1994;176:4034–2.PubMedGoogle Scholar
  48. Holmes  A, Zhou  H, Sun  L, Goldstein  R. Multiple chromosome variability amongst clinical and environmental isolates of Burkholderia (Pseudomonas) cepacia; Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 1996; San Francisco. San Francisco: ICAAC; 1995; Abstract C51.
  49. Allardet-Servent  A, Michaux-Charachon  S, Jumas-Bilak  E, Karayan  L, Ramuz  M. Presence of one linear and one circular chromosome in the Agrobacterium tumefaciens C58 genome. J Bacteriol. 1993;175:7869–74.PubMedGoogle Scholar
  50. Suwanto  A, Kaplan  S. Physical and genetic mapping of the Rhodobacter sphaeroides 2.4.1 genome: genome size, fragment identification, and gene localisation. J Bacteriol. 1989;171:5840–9.PubMedGoogle Scholar
  51. Michaux  S, Paillisson  J, Charles-Nurit  M, Bourg  G, Allardet-Servent  A, Ramuz  M. Presence of two independent chromosomes in the Brucella melitensis 16M genome. J Bacteriol. 1993;175:701–5.PubMedGoogle Scholar
  52. Mark  K, Titball  R. The detection of insertion sequences within the human pathogen Burkholderia pseudomallei which have been identified previously in Burkholderia cepacia. FEMS Microbiol Lett. 1998. In press.

Main Article

Page created: December 15, 2010
Page updated: December 15, 2010
Page reviewed: December 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external